Methylphenidate hydrochloride and Zetia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate hydrochloride and Zetia. Common interactions include drug hypersensitivity among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people who take Methylphenidate hydrochloride and Zetia have. It is created by eHealthMe based on reports of 10 people who take Methylphenidate hydrochloride and Zetia from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

10 people who take Methylphenidate hydrochloride and Zetia together, and have interactions are studied.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 5,263 Methylphenidate hydrochloride users for its effectiveness, alternative drugs and more.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 46,614 Zetia users for its effectiveness, alternative drugs and more.

Number of Methylphenidate hydrochloride and Zetia reports submitted per year:

Common Methylphenidate Hydrochloride and Zetia drug interactions by gender *:

female:

Drug hypersensitivity
Seizure
Anxiety
Bipolar disorder
Chronic kidney disease
Confusional state
Depression
Hypoglycaemia
Renal failure

male:

Abdominal pain
Abdominal pain upper
Vision blurred
Vomiting
Atrial fibrillation
Chest pain
Diarrhoea
Dyspnoea
Flatulence
Hypotension

Common Methylphenidate Hydrochloride and Zetia drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chest pain
Confusional state
Diarrhoea
Dyspnoea
Flatulence
Hypoglycaemia
Nausea
Oedema peripheral
Vision blurred
Vomiting

50-59:

n/a

60+:

Anxiety
Atrial fibrillation
Bipolar disorder
Chronic kidney disease
Depression
Hypotension
Renal failure

Common conditions people have *:

Pain: 2 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 10.00%
Oedema (fluid collection in tissue): 1 person, 10.00%
Mental Disorder Due To A General Medical Condition (abnormal a mental or behavioural pattern due to medicine): 1 person, 10.00%
Mental Disability: 1 person, 10.00%
Maxillofacial Sinus Neoplasm (tumour of face bone airspace): 1 person, 10.00%
Kidney Stones: 1 person, 10.00%
Infection: 1 person, 10.00%
Gout (uric acid crystals building up in the body): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate hydrochloride and Zetia?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .